Tag Archives: antiretroviral drugs

WHO’s PQP: How affordable antiretroviral and other treatments owe much to “little known part of WHO” reliant on two funders

By on .

In 1999, a small South Africa study revealed disturbing news about a medicine used in first line directly observed therapy for tuberculosis:  it contained the right amount of the most essential ingredient but testing showed it was not being absorbed into patients’ systems. If the small study was representative of what was happening on a […]

UNAIDS strategy: Speed HIV treatment coverage, address gaps to reach “15 by 15″

By on .

Remember 3 by 5? The intended ambitiousness of that goal, to supply lifesaving antiretroviral treatment to three million of the people globally who needed it by 2005, as well as the failure to reach, it said as much about the impact of years of neglect as it did about the world’s desire to make up […]

Infographic breaks link between death and taxes

By on .

“Nothing is certain but death and taxes.” With the grim association stirred by the old adage credited to Benjamin Franklin, selling taxpayers on the idea of chipping in more would seem to be a hard sell. But a new infographic from amfAR, the Foundation for AIDS Research, takes on the challenge with a novel appeal […]

Global Fund changes highlight opportunities, challenges

By on .

The Kaiser Family Foundation’s panel talk on changes at The Global Fund to Fight AIDS, Tuberculosis and Malaria, focused on the impact of reorganization at the charity at a time when scientific progress offers unprecedented chances for inroads against the diseases. Panelists Joanne Carter, executive director of RESULTS/RESULTS EDUCATION FUND, J. Stephen Morrison, senior vice […]

Looking toward Vienna: Dan Kuritzkes, MD

By on .

The International AIDS Conference starts up in less than a week in Vienna, Austria.  ScienceSpeaks is gathering thoughts from leaders in the field HIV/AIDS treatment, research and advocacy in the question and answer series “Looking toward Vienna.” Daniel R. Kuritzkes, MD, is a Professor of Medicine at Harvard Medical School. He is also the Head […]

For men and women in Africa, rectal microbicides are crucial

By on .

Here at the Microbicides 2010 conference in Pittsburgh I got a chance to talk with Dr. Gita Ramjee, one of the top researchers in the field, about the most exciting scientific challenges being discussed at the meeting.  Dr Ramjee is the Director of the HIV Prevention Research Unit at the South African Medical Research Council.  […]

Don't miss the April 1 online presentation on treatment as prevention

By on .

Can ARV treatment be used to prevent HIV infection?  What are the implications?  How far along is the science? Mark your calendar to hear an online presentation and discussion on treatment as prevention, Thursday, April 1 at 10am EDT. You can ask questions via the web as it is taking place, and you can also […]

Reactions to the New CSIS Report on "Smart Global Health Policy"

By on .

The Center for Strategic and International Studies yesterday unveiled  a new “must-read” report for global health advocates, “Smart Global Health Policy.” While a panel at the Congressionally-chartered Institute of Medicine, made up primarily of scientists, issued recommendations on US global health policy last year, the CSIS panel is the first to involve high-level business leaders […]

HIV/AIDS Physician-Scientists, Advocates Call for Bold HIV Treatment Goals for PEPFAR

By on .

Physician-scientists working on the frontlines of the HIV/AIDS epidemic today urged the White House to set bold new HIV treatment targets for PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief. The Center for Global Health Policy joined with a coalition of other organizations—including HealthGAP, amfAR (the Foundation for AIDS Research), the Treatment Action Group, […]

WHO Bulletin Examines Using ART to Prevent HIV Transmission

By on .

The World Health Organization’s latest bulletin is a must-read for experts and advocates working on global AIDS, delving into the hot topic of preventing HIV transmission with antiretroviral drugs and noting upcoming WHO action on this issue in the coming months. The bulletin, authored by Kevin M De Cock and others in the WHO’s Department […]